New drugs 2002, part III.
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001862:Bone Resorption / Q000188:drug therapy; D000077300:Bosentan; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use; D000068256:Darbepoetin alfa; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use; D017277:Drug Approval; D004358:Drug Therapy / Q000451:nursing / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D061267:Insulin Aspart; D053590:Interleukin 1 Receptor Antagonist Protein; D045283:Natriuretic Agents / Q000494:pharmacology / Q000627:therapeutic use; D020097:Natriuretic Peptide, Brain; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000494:pharmacology / Q000627:therapeutic use; D011486:Protein C / Q000494:pharmacology / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000494:pharmacology / Q000627:therapeutic use; D012795:Sialoglycoproteins / Q000494:pharmacology / Q000627:therapeutic use; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use; D000068698:Tenofovir; D014363:Tryptamines; D000077211:Zoledronic Acid
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D000959:Antihypertensive Agents; D018501:Antirheumatic Agents; D002511:Cephalosporins; D004164:Diphosphonates; D007004:Hypoglycemic Agents; C507763:IL1RN protein, human; D007093:Imidazoles; D007211:Indoles; D007328:Insulin; D053590:Interleukin 1 Receptor Antagonist Protein; D045283:Natriuretic Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011486:Protein C; D011994:Recombinant Proteins; D017366:Serotonin Receptor Agonists; D012795:Sialoglycoproteins; D013449:Sulfonamides; D014363:Tryptamines; D004921:Erythropoietin; D020097:Natriuretic Peptide, Brain; D000068256:Darbepoetin alfa; C409045:almotriptan; D000077211:Zoledronic Acid; C057710:cefditoren pivoxil; D000068698:Tenofovir; D061267:Insulin Aspart; D000225:Adenine; C421124:drotrecogin alfa activated; D000077300:Bosentan